Heart rate variability after bariatric surgery: The add-on value of exercise.


Journal

European journal of sport science
ISSN: 1536-7290
Titre abrégé: Eur J Sport Sci
Pays: England
ID NLM: 101146739

Informations de publication

Date de publication:
Mar 2023
Historique:
pubmed: 11 12 2021
medline: 10 3 2023
entrez: 10 12 2021
Statut: ppublish

Résumé

To assess the impact of bariatric surgery and an added supervised exercise training programme on heart rate variability (HRV) in patients with severe obesity. Fifty-nine patients who underwent bariatric surgery were randomised in the post-operative period to a 12-week supervised exercise training programme (moderate intensity combination aerobic/resistance exercise training programme) or a control group. Indices of HRV including time-domain, spectral-domain, and nonlinear parameters were measured preoperatively, and at 3, 6, and 12 months. After the surgical procedure, both groups improved anthropometric parameters. Type 2 diabetes, hypertension, and dyslipidemia resolutions were similar between groups. Total body weight loss at 6 and 12 months were also comparable between groups (6 months: 28 ± 6 vs. 30 ± 6%; 12 months: 38 ± 9 vs. 38 ± 10%; control vs. intervention group respectively). Bariatric surgery improved HRV parameters at 12 months compared to the pre-operative values in the intervention group: standard deviation of R-R interval (SDNN) (156.0 ± 46.4 vs. 122.6 ± 33.1 ms), low frequency (LF) (6.3 ± 0.8 vs. 5.8 ± 0.7 ms Bariatric surgery is associated with an improvement in HRV. A supervised exercise training programme in the post-operative period did not modulate further the benefits of bariatric surgery regarding HRV parameters.

Identifiants

pubmed: 34890532
doi: 10.1080/17461391.2021.2017488
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-422

Auteurs

D Belzile (D)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.

A Auclair (A)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.

J Roberge (J)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.

M E Piché (ME)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.
Faculty of medicine, Laval University, Québec, Canada.

A Lebel (A)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.

M Pettigrew (M)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.
Faculty of pharmacy, Laval University, Québec, Canada.

S Marceau (S)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.
Faculty of medicine, Laval University, Québec, Canada.

L Biertho (L)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.
Faculty of medicine, Laval University, Québec, Canada.

P Poirier (P)

Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.
Faculty of pharmacy, Laval University, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH